Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties
The DOI matches its Crossref record.
Abstract
Several studies describing the "natural history" of Peyronie's disease (PD) (Chronic Inflammation of the Tunica Albuginea-CITA) showed that untreated patients with PD seem to have spontaneous improvement. Because of these articles many physicians found to have a non-therapeutic behavior in case of PD. This paper tries to define the natural history of PD using penile dynamic duplex ultrasound evaluation in function of factors able to elicit fibrosis of the penis. Eighty-two patients have been studied, the mean time being between PD onset and diagnosis was 9.6 ± 3.8 months, mean age was 52.6 ± 10.69. Each patient underwent to two clinical assessments for PD, with a time-lag of 18.08 ± 9.2 months. Each assessment comprises: measurement of: plaque volume in cm(3) (with dynamic echocolor Doppler ultrasonography), penile curvature in degrees (with Kelami method), pain (with Pain Intensity Numerical Rating Scale/PINRS) and sexual function (with IIEF15 scale). The following clinical and laboratory assessments were carried out on each patient: body-mass index (BMI), blood pressure measurement, blood count, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, blood sugar, glycated haemoglobin and total testosterone. We assessed whether PD plaque volume, penile deformity, pain and modify by time, in function of risk factors of fibrosis (aging, smoking habit, erectile failure, number of comorbidities, BMI, radical prostatectomy) and/or of the severity of symptoms (plaque area, penile deformity and calcifications). Qualitative-quantitative non parametric multivariate analysis has been used as statistical test. The analysis indicated that PD symptoms increase by time in the majority of the patients, and that the increase is not linked to the severity of symptoms, but to the risk factors for developing fibrosis, with the exception of age that is inversely related. PD is a progressive disease, whose progression is linked to young age and to risk factors of fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, it is essential to note that while most patients have detectable plaque, some may be unaware of its presence.104,121,122”
From Research advances in Peyronie's disease: a comprehensive review on genomics, pathways, phenotypic manifestation, and therapeutic targets. (2024) · cites this paper as [122]
In the citing paper
“PD progresses in two main stages. The first phase typically lasts between 12 and 18 months; this phase is the “active inflammatory phase”, in which plaque forms and progresses to fibrosis and potential calcification, accompanied by pain and worsening of the penile deformity. In the second phase, known as the chronic “stabilized phase”, penile pain decreases and the plaque size and deformity stabil”
From Clinical Presentation of Peyronie’s Disease: A Retrospective Study of 564 Cases (2024) · cites this paper as [30]
Citations
Cited by
The Natural History of Peyronie’s Disease
Di Maida, F., Cito, G., Lambertini, L., Valastro, F., Morelli, G., Mari, A., Carini, M., Minervini, A., & Cocci, A. (2021) · The World Journal of Men's Health · doi:10.5534/wjmh.200065 · Cited by 59
“Active phase can manifest also with ED in a percentage of cases ranging from 22% to 54% [24].”
InfluentialIntralesional hyaluronic acid: an innovative treatment for Peyronie’s disease
Romano, G., Barletta, D., & Paulis, G. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1074-1 · Cited by 49
“It has been shown for some cases that an increase in the area of the disease (penile plaque) paradoxically led to an improvement in penile curvature [10].”
BackgroundSelf-citationPaulis, G., Cavallini, G., Giorgio, G., Quattrocchi, S., Brancato, T., & Alvaro, R. (2013) · Inflammation & Allergy-Drug Targets · doi:10.2174/1871528112666131205112432 · Cited by 39
“Our results showed that long-term multimodal treatment with Verapamil associated with Antioxidants and topical Diclofenac is statistically and significantly effective in treating PD, whereas, lower therapeutic responses were obtained after 6 months (medium-term treatment), also considering the “natural history” of PD…”
BackgroundSelf-citationPaulis, G., Romano, G., & Paulis, A. (2016) · Research and Reports in Urology · doi:10.2147/rru.s109319 · Cited by 36
Self-citationChi, J., Bi, W., Lou, K., Ma, J., Wu, J., & Cui, Y. (2024) · Sexual Medicine Reviews · doi:10.1093/sxmrev/qeae006 · Cited by 14
Metadata
- Authors
- Paulis, G., & Cavallini, G.
- Affiliations
- Ospedale Regina Apostolorum (IT)
- Venue
- Inflammation & Allergy-Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2013-09-01
- Volume
- 12
- Issue
- 5
- Pages
- 341-348
- ISSN
- 1871-5281 (ISSN-L)
- OpenAlex
- W2319536906
- Cited by
- 16
- References
- 0
- Citations by year
- 2025: 1 · 2024: 4 · 2023: 1 · 2021: 1 · 2020: 1 · 2018: 2 · 2016: 1 · 2015: 4 · 2013: 1
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Inflammation & Allergy - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
- Health Sciences › Medicine › Urology › Urological Disorders and Treatments
- Keywords
- Peyronie's disease, natural history (disease), penile fibrosis, tunica albuginea, plaque volume, penile curvature, penile pain, sexual function, risk factors, aging, smoking, erectile dysfunction, disease progression
- MeSH terms
- Adult, Age Factors, Aspartate Aminotransferases, Calcinosis, Fibrosis, Follow-Up Studies, Glycated Hemoglobin, Humans, Italy, Male, Middle Aged, Penile Erection, Penile Induration, Penis, Risk Factors, Comorbidity, Disease Progression, Ultrasonography, Doppler, Color
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties. https://app.cochat.ai/papers/10.2174/18715281113129990055
- The paper
- Paulis, G., & Cavallini, G. (2013). Clinical Evaluation of Natural History of Peyronie’s Disease: Our Experience, Old Myths and New Certainties. Inflammation & Allergy-Drug Targets. https://doi.org/10.2174/18715281113129990055
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.